Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 10/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17205675 | 0.91 | TRPV1 (0.84) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17202845 | 0.86 | TRPV1 (0.76) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17203130 | 0.83 | NPC1 (0.73) | TRPV1ALDH1A1HPGDATMPOLB | |
| SCHEMBL5348698 | 0.82 | CYP1A2 (0.90) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17205697 | 0.82 | TRPV1 (1.00) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17203305 | 0.81 | TRPV1 (1.00) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3266072 | 0.80 | HPGD (0.90) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17205764 | 0.80 | TRPV1 (0.66) | TRPV1BLMHPGDMEN1KMT2A | |
| SCHEMBL14034814 | 0.80 | TRPV1 (0.93) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL31527869 | 0.79 | CYP1A2 (0.79) | TRPV1CYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12390525-B2 | Constructs for enhancing immune responses | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2025-08-19 | — | — | US | claimed |
| CN-119787997-A | Circuit and method for reducing offset voltage of amplifier | 广东工业大学 | 2025-04-08 | — | — | CN | claimed |
| US-20250099421-A1 | Analgesic Therapeutics Based on conjugation of Biocompatible Polymers to Ion Channel Modulators | Relevium Medical (IE) | 2025-03-27 | — | — | US | claimed |
| US-20250032640-A1 | TARGETED DRUG DELIVERY-RELEASE AND KILLING OF DRUG RESISTANT TUMORS AND PATHOGENS | RUBHU BIOLOGICS INC (US) | 2025-01-30 | — | — | US | claimed |
| CN-118761222-A | Rapid design method and system for straight pipe welding fixture | 中航西安飞机工业集团股份有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-117894716-A | Process for preventing un-grown epitaxial products from flowing out to next station | 杭州中欣晶圆半导体股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-20240082312-A1 | COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-03-14 | — | — | US | claimed |
| CN-109963586-B | Biological fusion proteins as anti-malarial vaccines | 维克芙奥私人有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115785275-B | Anti-plasmodium antibody and application thereof | 东莞市朋志生物科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| US-11730769-B2 | Compositions and methods for Williams Syndrome (WS) therapy | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-08-22 | — | — | US | claimed |
| EP-4147715-A1 | BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES | VAC4all Pte. Ltd. (SG) | 2023-03-15 | — | — | EP | claimed |
| CN-115785275-A | Anti-plasmodium antibody and application thereof | 东莞市朋志生物科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20220409712-A1 | BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES | VAC4ALL PTE LTD (SG) | 2022-12-29 | — | — | US | claimed |
| WO-2022222352-A1 | REMOTE-SENSING PANCHROMATIC AND MULTISPECTRAL IMAGE DISTRIBUTED FUSION METHOD BASED ON RESIDUAL NETWORK | 海南大学 | 2022-10-27 | — | — | WO | claimed |
| US-20220331423-A1 | Constructs for Enhancing Immune Responses | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-10-20 | — | — | US | claimed |
| CN-114785114-A | High-voltage transformation ratio mixed mode two-phase power converter | 电子科技大学 | 2022-07-22 | — | — | CN | claimed |
| EP-3487526-B1 | BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES | VAC4ALL PTE LTD (SG) | 2022-07-06 | — | — | EP | claimed |
| CN-112775937-B | Self-adaptive robust control method and device for under-actuated hydraulic single-leg power-assisted exoskeleton | 合肥工业大学 | 2022-04-29 | — | — | CN | claimed |
| CN-112388616-B | Adaptive robust force control method and device for under-actuated support leg assistance exoskeleton | 合肥工业大学 | 2022-02-22 | — | — | CN | claimed |
| WO-2015162216-A1 | BIARYL AMIDE OR UREA DERIVATIVES AS TRPV1 LIGANDS | UNIVERSITA' DEGLI STUDI DI SIENA (IT) | 2015-10-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730769-B2 | Compositions and methods for Williams Syndrome (WS) therapy | MAG, PMP22, WDR77 | TRPV1 4573/4885CYP1A2 4855/4885CYP3A4 4885/4885 |
| US-20240082312-A1 | COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY | MAG, PMP22, WDR77 | TRPV1 4573/4885CYP1A2 4855/4885CYP3A4 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.